Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
|
Mid-range Performer
1926.8000
2.90
(
0.15
%)
NSE
Sep 01, 2025
15:31 PM
51.06% Gain from 52W Low
Volume:
415.5K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
23 May 2023
1926.80
0.15%
GLENMARK PHARMACEUTI
Sell:
Glenmark Pharmaceuticals Ltd.
by
Prabhudas Lilladhar
Target: 570
Recommendation
Target
Prabhudas Lilladhar
Glenmark Pharmaceuticals Ltd. has gained
50.65%
in the last 6 Months
More from Glenmark Pharmaceuticals Ltd.
Recommended
Market closes higher, Ashok Leyland to invest Rs 5,000 crore to develop batteries in India
Trendlyne Marketwatch |
01 Sep 2025, 03:59PM
Five Interesting Stocks Today - August 29, 2025
The Baseline |
29 Aug 2025
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
|
29 Jun 2020